Position:
Consultant in Infectious Diseases & General Medicine
Research Interests:
Aspergillosis
Infectious Diseases
Projects/ grants:
Principal Investigator: 'Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine (COV-COMPARE)'
Background:
Dr Iain Page is a Consultant in Infectious Diseases & General Medicine at the Western General Hospital in Edinburgh. He has a sub-specialist interest in Fungal Infections and in particular Chronic Pulmonary Aspergillosis (CPA) and is establishing a clinical service for CPA patients in collaboration with respiratory physician colleagues. He is also engaged in COVID-19 research and is Principal Investigator for the Valneva COVID vaccine trial and an Investigator for the Oxford vaccine trial and RECOVERY therapeutics trials in Edinburgh.
He completed medical school and junior doctor training in Edinburgh. From 2007 he combined specialist training in Infectious Diseases in Manchester with several years teaching and leading research projects in Malawi and Uganda. He completed his PhD on Chronic Pulmonary Aspergillosis in 2015 and was subsequently an Academic Clinical Lecturer at the UK National Aspergillosis Centre in Manchester, before returning to Edinburgh in 2020. He is secretary of CPANet, the European clinical network for CPA research.
Key Publications:
2019
Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. Page ID, Byanyima R, Hosmane S, Onyachi N, Opira C, Richardson M, Sawyer R, Sharman A, Denning DW. European Respiratory Journal. 2019. DOI: 10.1183/13993003.01184-2018
2018
Case Definition of Chronic Pulmonary Aspergillosis in Resource-ConstrainedSettings. Denning DW, Page ID, Chakaya J, Chakrabarti A, …27 others… Cole DC, Haileyesus G Emerging Infectious Diseases. 2018 Aug;24(8). doi: 10.3201/eid2408.171312.
2017
A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention. Godet C … Page ID, Seidel D, Salzer H. Journal of Antimicrobial Chemotherapy. 2017. doi:10.1093/jac/dkx390.
2016
Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA). Page I, Richardson M, Denning DW. Journal of Infection. 2016;72(2):240-9.
2015
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigates. Verweij P… Page I et.al. Drug Resistance Updates. 2015;21-22:30-40. doi: 10.1016/j.drup.2015.08.001
All Publications:
2018
Role of serological tests in the diagnosis of mold infections.. Richardson M & Page ID. Current Fungal Infection Reports 2018. Sept 5. https://doi.org/10.1007/s12281-018-0321-1.
Treatment of chronic pulmonary aspergillosis: current standards and future perspectives. Alastruey-Izquierdo A, … Page ID, Salzer HJF et al on behalf of CPAnet. Respiration. 2018 doi:10.1159/000489474
Siemens Immulite Aspergillus-specific IgG assay for chronic pulmonary aspergillosis diagnosis. Page ID, Richardson M & Denning DW. . Medical Mycology. 2018. doi:10.1093/mmy/myy024.
Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis. Page ID, Baxter C, Hennequin C, Richardson M, van Hoeyveld E, van Toorenenbergen A, Denning D. Diagnostic Microbiology and Infectious Diseases. 2018. https:doi.org/10.1016/j.diagmicrobio.2018.01.001.
2017
Elevated Aspergillus-specific antibody levels among HIV-infected Ugandans with pulmonary tuberculosis. Kwizera R, Ratanshi R, Page I et al. BMC Pulmonary Medicine. 2017(17):149.
Aspergillus serology – have we arrived yet? Richardson MD & Page ID. Medical Mycology. 2017 1;55(1):48-55 doi: 10.1093/mmy/myw116.
2016
Aspergillus nodules; another presentation of Chronic Pulmonary Aspergillosis. Muldoon, EG, Sharman A, Page I, Bishop P, Denning DW. BMC Pulmonary Medicine. 2016.
2015
Antibody testing in aspergillosis – quo vadis? Page ID, Richardson M, Denning D. Medical Mycology. 2015. 53(5): 417-439. doi:10.1093/mmy/myv020
2013
Screening HIV infected adults in Malawi for anaemia: need for a new haemoglobin threshold to determine eligibility for antiretroviral therapy. Page I, McKew S, Kudzala A, Fullwood C, van Oosterhout J and Bates I. International Journal of STD & AIDS. 2013; 24(6): 449-53.
2011
The impact of new National HIV Testing Guidelines at a District General Hospital in an area of high HIV sero-prevalence. Page I, Phillips M, Flegg P, Palmer R. Journal of the Royal College of Physicians of Edinburgh. 2011, 41:9-12.
Implementing the Surviving Sepsis Guidelines in a District General Hospital. Page I, Hardy GD, Fairfield J, Orr D, Nichani R. Journal of the Royal College of Physicians of Edinburgh 2011; 41:309-15.
